Css LLC Uni Qure N.V. Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.54 - $21.5 $243,864 - $360,598	-16,772 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $29,024 - $51,638	-1,434 Reduced 7.88%	16,772 $348,000
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $42,396 - $62,298	-1,630 Reduced 8.22%	18,206 $583,000
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $258,820 - $321,000	8,636 Added 77.11%	19,836 $611,000
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $327,488 - $470,736	11,200 New	11,200 $377,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.